Dr. Scott Gottlieb’s forthcoming departure from the U.S. Food and Drug Administration has sparked confidence in the tobacco industry while also leaving some uncertainty about what’s next on the regulatory front.

While there has been no immediate changes to policy or enforcement action based on Gottlieb’s decision to leave the agency, stock prices for tobacco companies rose Tuesday afternoon following the announcement. According to Nasdaq, Altria’s stock rose by 1.5 percent and British American Tobacco’s stock rose 1.9 percent.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]